Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07489053 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimizing Functional Recovery After Breast Cancer Treatment

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoint revised
    • Interventions: Individually tailored education and goal-setting to promote activity participation (Behavioral) to Individually tailored education (Behavioral), Individually tailored education and guided application to promote activity participation…
    • Secondary endpoints revised (4)
    • Study description shortened, about 1 word
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to determine the best way to promote participation in vocational, social, physical, and instrumental activities of daily living in people who have completed treatment for early stage breast cancer. The main question it aims to answer is: Which of the intervention components, alone or in combination, most effectively promote participation in vocational, social, physical, and instrumental activities of daily living? Participants will be asked to try one of 8 combination of three intervention components that have been shown to promote activity participation: (1) priority elicitation, (2) education, and (3) guided application involving goal setting, problem-solving and action planning.
Trial Details
NCT Number NCT07489053
Lead Sponsor MGH Institute of Health Professions
Collaborators: University of Alabama at Birmingham, University of South Alabama, Dartmouth-Hitchcock Medical Center
Conditions
(from sponsor)
Breast Neoplasms
Related terms Breast Neoplasms
Enrollment 352 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov